Literature DB >> 15970351

Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis.

Alessandro Cucchetti1, Marco Vivarelli, Fabio Piscaglia, Bruno Nardo, Roberto Montalti, Gian Luca Grazi, Matteo Ravaioli, Giuliano La Barba, Antonino Cavallari, Luigi Bolondi, Antonio Daniele Pinna.   

Abstract

BACKGROUND/AIMS: Recurrence of hepatocellular carcinoma (HCC) following surgical resection is influenced by parameters detectable on the resection specimen or through a biopsy. The prognostic significance of HCC doubling time (DT) after surgery has never been investigated.
METHODS: We evaluated 62 patients who underwent curative resection of a single HCC on cirrhosis; tumors were assessed before surgery on two subsequent occasions with the same imaging technique allowing the calculation of DT. The influence of tumor DT, clinical and pathological parameters on recurrence-rate and patients survival was assessed with uni- and multivariate analysis. Relationship between DT and pathological features was also analyzed.
RESULTS: Three-year recurrence rate was 32.3% (20 patients): this was significantly higher in the presence of DT shorter than 100 days (58 versus 18% when equal to or longer; P=0.008), microvascular invasion (59 versus 17% when absent; P=0.008) or tumor undifferentiation (54 versus 25% when well/moderately differentiated; P=0.015). DT was the only independent predictor of recurrence (P=0.005). Patients survival was affected by Child-Pugh class only. DT was significantly shorter in tumors with microvascular invasion (P=0.007), undifferentiation (P=0.003) and high alpha-fetoprotein levels (P=0.011).
CONCLUSIONS: DT is easy to estimate and indicates the prognosis of single HCCs prior to liver resection.

Entities:  

Mesh:

Year:  2005        PMID: 15970351     DOI: 10.1016/j.jhep.2005.03.014

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  16 in total

Review 1.  Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

Authors:  Umberto Cillo; Tommaso Giuliani; Marina Polacco; Luz Maria Herrero Manley; Gino Crivellari; Alessandro Vitale
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.

Authors:  Jong Kwan Kim; Hyung-Don Kim; Mi-Jung Jun; Sung-Cheol Yun; Ju Hyun Shim; Han Chu Lee; Danbi Lee; Jihyun An; Young-Suk Lim; Young-Hwa Chung; Yung Sang Lee; Kang Mo Kim
Journal:  Dig Dis Sci       Date:  2017-08-16       Impact factor: 3.199

3.  Prognostic significance of tumor doubling time in mass-forming type cholangiocarcinoma.

Authors:  Agostino Maria De Rose; Alessandro Cucchetti; Gennaro Clemente; Francesco Ardito; Ivo Giovannini; Giorgio Ercolani; Felice Giuliante; Antonio Daniele Pinna; Gennaro Nuzzo
Journal:  J Gastrointest Surg       Date:  2013-01-05       Impact factor: 3.452

4.  Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C.

Authors:  Takahisa Sato; Ryosuke Tateishi; Haruhiko Yoshida; Takamasa Ohki; Ryota Masuzaki; Jun Imamura; Tadashi Goto; Fumihiko Kanai; Shuntaro Obi; Naoya Kato; Shuichiro Shiina; Takao Kawabe; Masao Omata
Journal:  Hepatol Int       Date:  2009-08-06       Impact factor: 6.047

5.  Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time.

Authors:  Naoki Shingaki; Hideyuki Tamai; Yoshiyuki Mori; Kosaku Moribata; Shotaro Enomoto; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Jun Kato; Masao Ichinose
Journal:  Mol Clin Oncol       Date:  2013-09-17

Review 6.  Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.

Authors:  Gonzalo Sapisochin; Jordi Bruix
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

7.  Growth rate of locally recurrent hepatocellular carcinoma after transcatheter arterial chemoembolization: comparing the growth rate of locally recurrent tumor with that of primary hepatocellular carcinoma.

Authors:  Mikio Tezuka; Keiji Hayashi; Kazunori Kubota; Sachiko Sekine; Yoichi Okada; Hiroyasu Ina; Tetsuya Irie
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

8.  Prospective evaluation of microscopic extension using whole-mount preparation in patients with hepatocellular carcinoma: Definition of clinical target volume for radiotherapy.

Authors:  Weihu Wang; Xiaoli Feng; Tao Zhang; Jing Jin; Shulian Wang; Yueping Liu; Yongwen Song; Xinfan Liu; Zihao Yu; Yexiong Li
Journal:  Radiat Oncol       Date:  2010-08-23       Impact factor: 3.481

9.  Objective assessment of tumour response to therapy based on tumour growth kinetics.

Authors:  E Mehrara; E Forssell-Aronsson; P Bernhardt
Journal:  Br J Cancer       Date:  2011-07-26       Impact factor: 7.640

10.  Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.

Authors:  Piyush Nathani; Purva Gopal; Nicole Rich; Adam Yopp; Takeshi Yokoo; Binu John; Jorge Marrero; Neehar Parikh; Amit G Singal
Journal:  Gut       Date:  2020-05-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.